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Scaffolds produced with ceramics are commonly used as bone substitute. In this work calcium 
phosphate materials were used to produce the scaffolds, because HA and TCP have many similarities 
with bone tissue. For crystalline phase analysis the scaffolds were calcined at 750 °C and sintered at 
1330 °C. Electron microscopy images showed HA and TCP nanoparticles and the compounds were 
identified by Fourier transform infrared spectrometer. X-ray diffraction showed this material to be 
mostly crystalline. X-ray fluorescence identified chemical contaminants. X-ray micro computerized 
tomography produces tomographic images of the objects in 360°. In vitro testing was used to study 
cells behavior in contact with this material in a controlled environment.
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1. Introduction
Bone tissue implants require a material that it has 
adequate chemical composition and structure, providing 
mechanical properties and architecture as similar as possible 
to those of bone tissue.
The physiological rationale for the use of porous 
materials in bone tissue engineering is that the pores 
provide conditions for cells mobility and for vascularization 
throughout the scaffold1.
The scaffolds are 3D structures with interconnected 
pores, and pore size between 100 to 500 µm[2].
In bone tissue engineering, cell cultures are made 
directly in 3D structures with interconnected pores2, these 
structures act as scaffolds for cells to adhere proliferate 
and organize as the new tissue, and providing the desired 
similarities with mineralized extra cellular matrix3.
Hydroxyapatite, Ca10 (PO4)6 (OH)2, is used for bone 
tissue replacement, because it is considered as a bioactive 
and osteoconductive material, besides being very similar to 
the mineral phase of bone tissue4.
Beta-tricalcium phosphate [β-Ca3 (PO4)2] (β-TCP) and 
alpha-tricalcium phosphate [α-Ca3 (PO4)2] (α-TCP) are 
easily resorbed when implanted in vivo. The resorption 
process gradually occurs according with growing of natural 
tissue that occupies the space of the synthetic implant5, and 
restores natural function.
β-TCP has received great attention between bioceramists 
and its main application is as bone cement for filling small 
facial defects. It can also be used for the fabrication of 
ceramic composites reinforced with others ceramics (dense 
or porous)6. The particle size distribution for application as 
bone cement or for ceramic composite is a crucial factor 
to obtain materials with adequate chemical, biological and 
mechanical properties.
The α-TCP phase is generated after heat-treatment 
transformation of β-TCP. Phase transformation occurs at 
approximately 1150 °C[7].
The aim of this study was to obtain and characterize 
scaffolds of HA / TCP obtained by sucrose leaching method 
to be applied as a new materials in bone tissue engineering.
2. Material and Methods
To produce the scaffolds the following steps were 
taken: i) Mixing HA Fluidinova nanoXIM-HAp202 
article 50120208 and TCP Fluidinova nanoXIM -TCP202 
article 50220208 (25 wt. % each one); ii) Addition of 
sucrose (50 wt. % with particles size between 100 to 
400 µm - Merck, Brazil) and thorough mixing; iii) Die 
compaction process (cylindrical mold) - single action, where 
an uniaxial pressing pressure is applied through the top 
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punch; iv) Leaching process to eliminate the porogenic agent 
(sucrose); v) Scaffold A calcined at 725 °C; and vi) Scaffold 
B sintered at 1330 °C[8].
2.1. X-Ray Fluorescence (XRF), X-Ray 
Diffraction (XRD) and X-Ray Micro 
Computed Tomography (Micro-CT)
Impurities presence was determined by XRF using 
a Rigaku RIX-3100 spectrometer. The samples were 
conformed into disks under mechanical compression and 
analyzed with a semi-quantitative routine.
The crystalline phases of scaffolds were determined by 
XRD using a Rigaku DMAX 2200 diffractometer provided 
with Cu-Kα (λ= 1.5406) radiation and Ni filter, 40kV and 
30mA. The diffractograms were taken under 0.01°.s-1 
velocity at a 2θ range varying from 26 to 38°.
Micro-CT was used to verify the interconnected 
pores, distribution and size. With the images generated by 
Micro-CT SkyScan 1074 it was possible to create 3D models 
that could be cut, and thus visualize the internal porosity 
of materials. The image capture software was the Control 
SkyScan 1074. The software for data analysis was the CTAn. 
The software used to create the 3D model was the ANT. The 
parameters for Micro-CT analyses were 1500 ms exposure 
to radiation with 40 kV, and 1000 mA and with step of 0.9° 
each advance. The reconstruction chosen was 360°.
2.2. Fourier Transformed Infrared analysis 
(FT-IR), Scanning Electron Microscopy 
(SEM), pycnometer analysis and uniaxial 
compression tests with axial load
Infrared spectra analysis was performed with a Thermo 
Scientific Nicolet IR100 FT-IR spectrometer with spectral 
resolution between 128 to 4 cm–1. The spectral range used 
was 3400 to 400 cm–1. For this analysis the samples were 
mixed with KBr (potassium bromide) and compacted.
Particle morphology and particle size of HA and TCP 
were analyzed using an environmental scanning electron 
microscope FEI Quanta 400 FEG ESEM (CEMUP). The 
SEM JEOL JXA-840A was used to analyze the scaffolds 
after contact with Sörensen buffer solution. The samples 
were coated with thin gold film by sputtering, to become 
conductive.
The equipment ultrapyc 1200e Quantachrome 
pycnometer was used to determine the porosity of the 
scaffolds. Were used: i) Dry helium gas, ii) 3 consecutive 
measurements with the pressure chamber constant at 
18 psig, and iii) Filling of gas chamber occurs within 1 min.
For uniaxial compression tests was used the Hounsfield 
testing equipment - model HT400 Pneumatic Grip 
Controller H. The velocity of equipment was 5 mm/min. 
with load cell of 5000N.
2.3. Cell culture, fixation, staining procedure, 
confocal microscope
Human bone osteosarcoma cells were cultured in 
α - MEM containing 10% fetal bovine serum, 100µg ml–1 
penicillin, 10 IU ml–1 streptomycin, 2.5 mg ml–1 fungizone 
and 50 mg ml–1 ascorbic acid (5% CO2 atmosphere, at 
37 °C). After subculturing, the cells were washed with PBS 
(Gibco, UK). Cells were removed from the culture plate 
after application of trypsin solution at 37 °C for 5 minutes. 
The scaffold and controls (culture plate) were seeded at the 
concentration of 105 cells/cm–2.
The scaffold and the control group were pre-incubated 
in medium at 37 °C for 1h in 5% CO2 atmosphere9.
The culture medium was changed twice a week. The 
scaffolds after being seeded were observed by optical 
microscopy after 2 days and confocal laser scanning 
microscopy after 7 days of culture.
The cells were fixed and stained using a protocol found 
in literature9.
With the confocal laser scanning fluorescence 
microscopy (Leica TCP SP2 AOBS) it was possible to 
increase the phase contrast image. In this work filaments of 
the cytoskeleton (green fluorescence) and nuclear proteins 
(red fluorescence) were colored.
2.4. Surface analysis after contact with Sörensen 
buffer solution
Sörensen buffer solution is a standard buffer solution 
routinely used in biochemistry, because of this, it was used 
to analyze the behavior of scaffold B in contact with this 
solution after 14 days under controlled pH and temperature 
(pH 7.5 and 70 °C)10.
The preparation methods for Sörensen buffer solution 
were conducted according to the standard ABNT NBR 
ISO15814: 2003[10].
3. Results and Discussion
3.1. XRF
The XRF results (Table 1) showed that both HA and TCP 
had low levels of impurities and none of the applied materials 
was considered as a hazardous chemical for applications as 
biomaterials, in accordance with ASTM F1185-03[11].
3.2. SEM, FT-IR and XRD
In Figure 1a e b aggregates of HA and TCP nanoparticles, 
respectively, are shown. These materials were used to 
produce the scaffolds. As it may be seen in the figure, both 
materials present nanoparticles, but the morphology of HA 
crystals is spherical while TCP’s is needle-like.
The presence of the bands at 630 cm–1 and 3570 cm–1 in 
the literature is related to the presence of hydroxyapatite12. 
Bands in the range of 1440-1400 cm–1 are evidence of 
the presence of vibration of the group (CO3)2–, which is a 
characteristic of carbonated hydroxyapatite.
Mineral apatite normally have as general formula 
Ca5(PO4)3#, where # can be OH, F, Cl or a mixture of these 
ions. For hydroxyapatite, the extra ion must be hydroxide.
Table 1. XRF Semi-quantitative analysis of impurities of HA and 
TCP powder (wt. %).
Samples K Na Sr S Ni
HA 0.0490 0.0111 0,0072 0.0213 0.0056
TCP 0.2556 0.1714 0.0116 0.0115 0.0046
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Calcium orthophosphates are salts of phosphoric acid 
H3PO4 tribasic (reagent used in the synthesis of HA and 
TCP) which may form compounds containing ions (H2PO4)–, 
(HPO4)2– or (PO4)3–.
Calcium phosphate is the most important inorganic 
constituents of biological hard tissues13,14, for example, 
bones, teeth and also in various pathological calcifications.
Calcium phosphate contain calcium ions (Ca2+) together 
with orthophosphates (PO4)3– and occasionally hydrogen or 
hydroxide ions.
The FT-IR spectra show bands of phosphate (PO4)3– at 
880, 867, 804, 503 and 472 cm–1 and the bands of hydroxyl 
(OH)– were detected around at 3000 cm–1 and 540 cm–1 
in the samples TCP and HA (Figure 1). The major bands 
present at region of 3000 cm–1 are water (H2O) adsorbed 
on the materials. The bands of the carbonate group (CO3)2– 
are recorded at 1400, 1370, 1188 and 730 cm–1. Samples 
showed peaks related to carbonate group, a fact which can 
be due to adsorption of ions (CO3)2– from the atmosphere. 
The tendency is for the (CO3)2– group to disappear after 
sintering, so it is believed that this group originates from 
Figure 1. (a) Agglomerates of spherical hydroxyapatite nanoparticle. (b) Agglomerates of beta-tricalcium phosphate nanoneedles. FTIR 
analyses where, (HA): Hydroxyapatite and (TCP): β-tricalcium phosphate. (Non-heat treated HA and TCP).
Figure 2. (a) Pores on scaffold A calcined at 725 °C. In the details of “Figure a” surface morphology at higher magnification may be seen 
and the XRD analysis (b: beta-TCP; p: pyrophosphate; HA: hydroxyapatite). (b) Pores on scaffold B sintered at 1330 °C. In the details of 
“Figure b” is shown the surface of scaffold, and the XRD analysis (a: peak of the alpha-tricalcium phosphate; HA: peak of hydroxyapatite).
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the CO2 present in atmospheric air9. Grouping bands 
hydrogenphosphate (HPO4)2– match between position 2200 
and 1900 cm–1.
Figure 2 showed the scaffolds calcined at 725 °C (a) and 
sintered at 1330 °C (b). Some modifications on the surface 
as shape and scaffold size, it can be noted, but it is due to 
the sintering temperature that modifies the structure of the 
material that undergoes this type of heat treatment. In this 
image it is possible to see the microporosity at the scaffold. 
Materials with rounded edges are good for cell adhesion.
In Figure 2a Scaffold A shows the pores between 
100 at 900 µm, and we can see in the upper left corner of 
this image that the scaffold shows an irregular surface with 
nanostructure formation. Figure 2a presents the XRD of the 
scaffold HA/β-TCP calcined at 725 °C.
Figure 2b shows the XRD diffractogram of the scaffold 
HA/α-TCP sintered at 1330 °C. The sintering temperature 
exceeded the phase change point, where beta phase is 
converted to alpha phase, therefore the samples showed 
peaks of α-TCP. Hydroxyapatite presented a stable phase.
3.3. Micro-CT, pycnometer analysis and 
mechanical compression test
To show the structure of scaffold obtained by sucrose 
crystal leaching it was done Micro-CT only on scaffold B 
due to ease of handling, and represents the final product.
Figure 3a presents a slice (2D image) of the scaffold B 
inner region obtained by Micro-CT, where it is possible to 
observe the sample’s porosity.
Figure 3b shows the projection of the 3D scaffold, and 
it was possible to visualize the external morphology of the 
scaffold and the pores.
Figure 3c shows a section of 3D image of scaffold B, 
and the pores distribution within the scaffold. It was found 
that the pores were interconnected.
The scaffold A presents 61% and Scaffold B 49% 
porosity (Table 2), these results are close of the expected 
value (50%).
Such a high porosity affects directly the mechanical 
strength of the scaffold, but it is required that pores are 
interconnected so that they might allow for the physiological 
fluids to flow, otherwise also vascularization and access of 
proteins during bone tissue regeneration would be impaired.
The data of thickness structure and pore size of scaffold 
B may be seen in Figure 3 on the right side. The average 
thickness of the scaffold structure was 168 µm and the value 
of average pore diameter around 937 µm. The high value 
was due to the union of two or more sucrose particles during 
compaction process.
The scaffold B reached a maximum average load of 23.1 
N, which was low due to the high porosity found.
Data from literature on the compressive strength of 
HA scaffolds with porosities of 61-65% was between 
1.5-1.8 MPa, these values were close to those obtained 
here15.
Figure 3 shows the results obtained with uniaxial 
compression test with axial load performed on scaffolds B. 
It presents values for the Elastic modulus (E), the maximum 
load (P) and the average value of the axial compressive 
stress (σca).
3.4. In vitro test
Figure 4 showed the cells adhered on scaffolds after 
2 days. Where Figure 4a is scaffold A, and Figure 4b is 
scaffold B.
Figure 5 showed the scaffolds after 7 days of cell culture. 
Figure 5a showed the scaffold A, with some adherent cells on 
its surface. On detail a stained cell may be seen. Figure 5b 
shows scaffold B. This scaffold shows adherent cells. This 
result indicates that scaffolds are not cytotoxic.
3.5. Surface analysis after contact with Sörensen 
buffer solution
Figure 6 shows scaffold B after 14 days in contact with 
Sörensen buffer solution. The morphology of the sintered 
alpha-TCP (Figure 2b) was modified after contact with 
Table 2. Results of pycnometer analysis.
Sample Open Cell (%)
Scaffold A 61 ± 0.6
Scaffold B 49 ± 0.1
Figure 3. (a) 2D slice obtained using the Micro-CT. (b) 3D projection (this is a union of all the 2D slices). (c) Internal architecture of 
porous scaffold B. On left side of picture are the results of mean values of thickness and pore diameter obtained from Micro-CT and the 
results of mechanical compression test (E, P and σ
ca
).
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Figure 6. HA/TCP scaffold after 14 days in contact with Sörensen buffer solution. (a) External surface; (b) Fracture surface where, TCP: 
alpha-tricalcium phosphate; and HA: hydroxyapatite.
Figure 4. Cells adhered on scaffolds after 2 days. (a) Scaffold A. (b) Scaffold B. Zoom: 20x.
Figure 5. Cells adhered on scaffolds after 7 days. (a) Scaffold A. (b) Scaffold B.
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buffer solution (Figure 6), but this is a typical morphology 
of alpha-TCP[16], mainly after contact with this type of 
solution. The morphology of hydroxyapatite apparently 
remained stable.
4. Conclusion
In vitro tests showed that both scaffolds (A and B) 
probably have conditions to provide adhesion and cell 
spreading.
In cell culture both scaffolds showed good results, but 
the scaffold B showed better condition in the handling 
process in all steps of this work.
With FTIR, XRD and SEM the materials, structure and 
morphology of scaffolds were identified.
The XRF analysis showed the presence of residual 
amounts of contaminants, none of which was considered 
hazardous for applications as biomaterial in the amounts 
found.
With the micro-CT was possible to visualize the internal 
structure of the scaffold and with pycnometer analysis 
was possible quantified the porosity, that was close of the 
expected value.
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